Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

466 results

Abstracts - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

First report of outcomes in the TRILUMINATE pivotal clinical trial in patients with severe tricuspid regurgitation

21 Sep 2022

Alex Sticchi provides his take on the TRILUMINATE pivotal trial which was presented by David H. Adams at the TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients with Severe Tricuspid Regurgitation

The tricuspid valve: from diagnosis to repair. An Asian perspective

19 Aug 2022

Watch the replay of the 5th of #PCRtokyo 2022’s six live webinars. You’ll learn all about ‘The tricuspid valve: from diagnosis to repair. An Asian perspective'

The tricuspid valve: from diagnosis to repair. An Asian perspective

Complex mitral and tricuspid intervention - the PCR Valves e-Course revisited

19 Jan 2021

Watch the replay of this PCR Webinar on tricuspid valve disease with with B. Prendergast, N. Dumonteil, S. Redwood and D. Tchétché.

Complex mitral and tricuspid intervention - the PCR Valves e-Course revisited

Imaging the journey of a patient with severe tricuspid regurgitation: from diagnosis to management

22 Dec 2021

Tricuspid valve lifetime management

09 Aug 2022

Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib

Tricuspid valve interventions: patient and device selection

09 Aug 2022

PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig

Tricuspid valve interventions: patient and device selection

Natural history and prognosis of tricuspid valve disease

04 Aug 2022

PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair

21 Jun 2022

As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.

Jonathan Curio

Reviewer

Jonathan Curio
Alessandro Sticchi

Reviewer

Alessandro Sticchi
Dr. Gilbert Tang

Reviewer

Gilbert Tang
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair

The PCR Tricuspid Focus Group at EuroPCR 2022

02 Jun 2022

 

During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.

The PCR Tricuspid Focus Group at EuroPCR 2022